Cargando…

Complement Activation and Regulation in Preeclamptic Placenta

Preeclampsia (PE) is a common disorder of pregnancy originating in the placenta. We examined whether excessive activation or poor regulation of the complement system at the maternal–fetal interface could contribute to the development of PE. Location and occurrence of complement components and regula...

Descripción completa

Detalles Bibliográficos
Autores principales: Lokki, Anna Inkeri, Heikkinen-Eloranta, Jenni, Jarva, Hanna, Saisto, Terhi, Lokki, Marja-Liisa, Laivuori, Hannele, Meri, Seppo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088925/
https://www.ncbi.nlm.nih.gov/pubmed/25071773
http://dx.doi.org/10.3389/fimmu.2014.00312
_version_ 1782325056891781120
author Lokki, Anna Inkeri
Heikkinen-Eloranta, Jenni
Jarva, Hanna
Saisto, Terhi
Lokki, Marja-Liisa
Laivuori, Hannele
Meri, Seppo
author_facet Lokki, Anna Inkeri
Heikkinen-Eloranta, Jenni
Jarva, Hanna
Saisto, Terhi
Lokki, Marja-Liisa
Laivuori, Hannele
Meri, Seppo
author_sort Lokki, Anna Inkeri
collection PubMed
description Preeclampsia (PE) is a common disorder of pregnancy originating in the placenta. We examined whether excessive activation or poor regulation of the complement system at the maternal–fetal interface could contribute to the development of PE. Location and occurrence of complement components and regulators in placentae were analyzed. Cryostat sections of placentae were processed from 7 early-onset PE (diagnosis <34 weeks of gestation), 5 late-onset PE, 10 control pregnancies, and immunostained for 6 complement activators and 6 inhibitors. Fluorescence was quantified and compared between PE and control placentae. Gene copy numbers of complement components C4A and C4B were assessed by a quantitative PCR method. Maternal C4 deficiencies (≥1 missing or non-functional C4) were most common in the early-onset PE group (71%), and more frequent in late-onset PE compared to healthy controls (60 vs. 38%). Complement C1q deposition differed significantly between control and patient groups: controls and early-onset PE patients had more C1q than late-onset PE patients (mean p = 0.01 and p = 0.005, respectively). C3 activation was analyzed by staining for C3b/iC3b and C3d. C3d was mostly specific to the basal syncytium and C3b/iC3b diffuse in other structures, but there were no clear differences between the study groups. Activated C4 and membrane-bound regulators CD55, CD46, and CD59 were observed abundantly in the syncytiotrophoblast. Syncytial knots, structures enriched in PE, stained specifically for the classical pathway inhibitor C4bp, whereas the key regulator alternative pathway, factor H (FH) showed a wider distribution in the placenta. Differences in C1q deposition between late- and early-onset PE groups may be indicative of the different etiology of PE symptoms in these patients. Irregular distribution of the complement regulators C4bp and FH in the PE placenta and a higher frequency of C4A deficiencies suggest a disturbed balance between complement activation and regulation in PE.
format Online
Article
Text
id pubmed-4088925
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-40889252014-07-28 Complement Activation and Regulation in Preeclamptic Placenta Lokki, Anna Inkeri Heikkinen-Eloranta, Jenni Jarva, Hanna Saisto, Terhi Lokki, Marja-Liisa Laivuori, Hannele Meri, Seppo Front Immunol Immunology Preeclampsia (PE) is a common disorder of pregnancy originating in the placenta. We examined whether excessive activation or poor regulation of the complement system at the maternal–fetal interface could contribute to the development of PE. Location and occurrence of complement components and regulators in placentae were analyzed. Cryostat sections of placentae were processed from 7 early-onset PE (diagnosis <34 weeks of gestation), 5 late-onset PE, 10 control pregnancies, and immunostained for 6 complement activators and 6 inhibitors. Fluorescence was quantified and compared between PE and control placentae. Gene copy numbers of complement components C4A and C4B were assessed by a quantitative PCR method. Maternal C4 deficiencies (≥1 missing or non-functional C4) were most common in the early-onset PE group (71%), and more frequent in late-onset PE compared to healthy controls (60 vs. 38%). Complement C1q deposition differed significantly between control and patient groups: controls and early-onset PE patients had more C1q than late-onset PE patients (mean p = 0.01 and p = 0.005, respectively). C3 activation was analyzed by staining for C3b/iC3b and C3d. C3d was mostly specific to the basal syncytium and C3b/iC3b diffuse in other structures, but there were no clear differences between the study groups. Activated C4 and membrane-bound regulators CD55, CD46, and CD59 were observed abundantly in the syncytiotrophoblast. Syncytial knots, structures enriched in PE, stained specifically for the classical pathway inhibitor C4bp, whereas the key regulator alternative pathway, factor H (FH) showed a wider distribution in the placenta. Differences in C1q deposition between late- and early-onset PE groups may be indicative of the different etiology of PE symptoms in these patients. Irregular distribution of the complement regulators C4bp and FH in the PE placenta and a higher frequency of C4A deficiencies suggest a disturbed balance between complement activation and regulation in PE. Frontiers Media S.A. 2014-07-09 /pmc/articles/PMC4088925/ /pubmed/25071773 http://dx.doi.org/10.3389/fimmu.2014.00312 Text en Copyright © 2014 Lokki, Heikkinen-Eloranta, Jarva, Saisto, Lokki, Laivuori and Meri. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Lokki, Anna Inkeri
Heikkinen-Eloranta, Jenni
Jarva, Hanna
Saisto, Terhi
Lokki, Marja-Liisa
Laivuori, Hannele
Meri, Seppo
Complement Activation and Regulation in Preeclamptic Placenta
title Complement Activation and Regulation in Preeclamptic Placenta
title_full Complement Activation and Regulation in Preeclamptic Placenta
title_fullStr Complement Activation and Regulation in Preeclamptic Placenta
title_full_unstemmed Complement Activation and Regulation in Preeclamptic Placenta
title_short Complement Activation and Regulation in Preeclamptic Placenta
title_sort complement activation and regulation in preeclamptic placenta
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088925/
https://www.ncbi.nlm.nih.gov/pubmed/25071773
http://dx.doi.org/10.3389/fimmu.2014.00312
work_keys_str_mv AT lokkiannainkeri complementactivationandregulationinpreeclampticplacenta
AT heikkinenelorantajenni complementactivationandregulationinpreeclampticplacenta
AT jarvahanna complementactivationandregulationinpreeclampticplacenta
AT saistoterhi complementactivationandregulationinpreeclampticplacenta
AT lokkimarjaliisa complementactivationandregulationinpreeclampticplacenta
AT laivuorihannele complementactivationandregulationinpreeclampticplacenta
AT meriseppo complementactivationandregulationinpreeclampticplacenta